Kevin Young Xu, MD MPH

Delighted to start my @NIDAnews K08 award using claims data to optimize opioid use disorder tx in pregnancy. So grateful for my mentors &collaborators-Rick Grucza, Laura Bierut @ebonycartermd @LarochelleMarc @HendreeJ @StopkaThomas Paul Wesson, Anne Mobley Butler, Kenton Johnston

No words.

Real-time administrative data suggests that #stiripentol, #fenfluramine, and, to an extent, #cannabidiol may be underused in a large, diverse, primarily US-based population of pts with #Dravet syndrome. @KevinYXu @TheNotoriousEEG @IlaeWeb @EpilepsiaOpen onlinelibrary.wiley.com/doi/10.1002/ep…

40% of patients receiving Epidiolex® did not have FDA-approved diagnostic indications (#LGS, #DravetSyndrome, #TSC) in the medical record. This real-world data analysis👇 examines #CBD prescribing practices in the US. @KevinYXu sciencedirect.com/science/articl…

Grateful be covered by the platform to romote neuodiveristy research MINDS from Queen Mary University of London. linkedin.com/posts/minds-ne…

@MorganCShields This is incredibly eye opening and frankly mind blowing to see... Can't wait to hear about it in more detail when you're back in STL! Thx so much for sharing and educating us in live time during your travels!

New study published in BMJ Neurology Open found most individuals on benzodiazepine treatment before psychogenic non-epileptic seizure diagnosis continued BZD treatment. @fabnascimen @kevinyxu @HillarySamples @GretaBushnell @taewooparkmd @LinYezhe bit.ly/3XZWdah

Thank you to @HillarySamples @GretaBushnell @taewooparkmd @fabnascimen @LinYezhe Donovan Maust for the team work in getting this data out

To be clear, we are not advocating for the deprescribing (or prescribing) of BZDs in PNES. I do hope this data can help clinicians pause, check the med list, and expand the differential diagnosis before jumping to consult psychiatry or tell the patient “it’s all in your head.”

We have a new paper out in BMJ Neuro on “psychogenic nonepileptic seizures” #PNES There's often a notion that PNES is “untreatable” or “purely psychiatric.” But our study suggests MDs may want to first review &reconcile the med list before jumping the gun neurologyopen.bmj.com/content/6/2/e0…

In our latest paper, we emphasize the need for quantitative summaries of adverse events data to complement anecdotes and drive discourse on the risks and benefits of psychedelic research.

@Tralfamadoctor @CPDDorg @washupsychres Shout out to allstar coauthors @HendreeJ @jchenkelly @ebonycartermd @DrCaitlinmartin @CarrieMintzMD Frances Levin & Rick Grucza Our group is currently analyzing postCOVID data on a general sample of pregnant people w/ADHD to assess stimulant receipt patterns-Stay tuned for more!

This is the brainchild of psychiatry resident, @Tralfamadoctor--who presented this as a late breaking talk at @CPDDorg exactly 1 yr ago (while 30 wks pregnant!--and was recently interviewed for a university press release. Congrats Tiffani! medicine.wustl.edu/news/adhd-meds… @washupsychres

New pub alert in @NatMentHealth - Among pregnant people w/ opioid use disorder, almost no one in methadone clinics is getting treatment for ADHD. ADHD meds are more common in the bupe setting and are associated w/ ↑ treatment retention & ↓ overdoses. nature.com/articles/s4422…

Eating disorders treatment is often siloed from the rest of psychiatry. Thus it's gratifying to see our work w/ superstar @LinYezhe (incoming UCSF CAP fellow), Angela Liu, Dom Moog + Hui Xie get national media coverage w/commentary from APA president medscape.com/viewarticle/ps…

Wonderful sharing the stage at the APA annual meeting in NYC w/ @SonyaGabrielian @RochelleObiekwe & Kim Miller @CDCgov to share new data on combating overdose among people experiencing homelessness. Big thanks to Wilson Compton @NIDAnews for bringing us together #APAAM24

My pleasure to be back at the ASAM Ruth Fox Scholarship Meeting as the selection committee member and the former scholar! Congratulations, new scholars 🎊#ASAM #AC2024 @ASAMorg #MedEd